http://rdf.ncbi.nlm.nih.gov/pubchem/reference/25011297

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 3130
issn 0304-4165
issueIdentifier 12
pageRange 3120-3130
publicationName Biochimica et Biophysica Acta (BBA) - General Subjects
startingPage 3120
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e08353b5a6d96c72c91e23843c4ef5d1
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_7c06f1f1553db51882f94110b7c49f46
bibliographicCitation Yuzhakova DV, Lermontova SA, Grigoryev IS, Muravieva MS, Gavrina AI, Shirmanova MV, Balalaeva IV, Klapshina LG, Zagaynova EV. In vivo multimodal tumor imaging and photodynamic therapy with novel theranostic agents based on the porphyrazine framework-chelated gadolinium (III) cation. Biochimica et Biophysica Acta (BBA) - General Subjects. 2017 Dec;1861(12):3120–30. doi: 10.1016/j.bbagen.2017.09.004.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4b9ec55e2afea9e5b7614c0a73bf8145
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_92245ed3317c87f2857a9edc796a653b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c0fd3ff13be705ce69bd2247084f2dec
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d83edb6bdac13243bea4cbfca7266eff
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c00ff2b401953e1633508860d8a8346a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c87b34d4e74e76e82749ae2bdf024750
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_044c03a52be1943f042d5578c30cd0e9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c8da2fbd28ce548336c0e4e47ac4d82b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8f04a143c106f790a52c0f88b9b28449
date 201712
identifier https://pubmed.ncbi.nlm.nih.gov/28916141
https://doi.org/10.1016/j.bbagen.2017.09.004
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/47937
https://portal.issn.org/resource/ISSN/0304-4165
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title In vivo multimodal tumor imaging and photodynamic therapy with novel theranostic agents based on the porphyrazine framework-chelated gadolinium (III) cation
discusses http://id.nlm.nih.gov/mesh/M0008930
http://id.nlm.nih.gov/mesh/M0004002
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D064847
http://id.nlm.nih.gov/mesh/D010778
http://id.nlm.nih.gov/mesh/D009369Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D002614Q000008
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D005682
http://id.nlm.nih.gov/mesh/D005453
http://id.nlm.nih.gov/mesh/D008807
http://id.nlm.nih.gov/mesh/D009369Q000000981
http://id.nlm.nih.gov/mesh/D008279
http://id.nlm.nih.gov/mesh/D045744
http://id.nlm.nih.gov/mesh/D051379
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_beda6fe677b7a43d27c994ffcbd5e2d6
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7306
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID168050

Total number of triples: 47.